Jan-16 -

Genito-Urinary Group

EORTC 30994 – Randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder.

EORTC’s study comparing two treatment regiments with a seven-year follow-up, in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder, found that even though immediate chemotherapy did not improve overall survival, it improved progression free survival in these patients.

READ MORE

Go to Top